A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

NCT00635076 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Please see Detailed Description for the termination reason.

Conditions

Panic Disorder

Interventions

OTHER: placebo
DRUG: alprazolam XR

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.